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Abstract
Background: Over the last two decades, many epidemiological studies were performed to describe risks and
clinical presentations of melioidosis in endemic countries.
Methods: We performed a retrospective analysis of 158 confirmed cases of melioidosis collected from medical
records from 2001 to 2015 in Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia, in order to
update the current status of melioidosis clinical epidemiology in this putatively high risk region of the country.
Results: Principal presentations in patients were lung infection in 65 (41.1 %), skin infection in 44 (27.8 %), septic
arthritis/osteomyelitis in 20 (12.7 %) and liver infection in 19 (12.0 %). Bacteremic melioidosis was seen in most of
patients (n = 121, 76.6 %). Focal melioidosis was seen in 124 (78.5 %) of patients and multi-focal melioidosis was
reported in 45 (28.5 %) cases. Melioidosis with no evident focus was in 34 (21.5 %) patients. Fifty-four (34.2 %)
patients developed septic shock. Internal organ abscesses and secondary foci in lungs and/or soft tissue were
common. A total of 67 (41 %) cases presented during the monsoonal wet season. Death due to melioidosis was
reported in 52 (32.9 %) patients, while relapses were occurred in 11 (7.0 %). Twelve fatal melioidosis cases seen in this
study were directly attributed to the absence of prompt acute-phase treatment. Predisposing risk factors were reported in
most of patients (n = 133, 84.2 %) and included diabetes (74.7 %), immune disturbances (9.5 %), cancer (4.4 %) and
chronic kidney disease (11.4 %). On multivariate analysis, the only independent predictors of mortality were the presence
of at least one co-morbid factor (OR 3.0; 95 % CI 1.1–8.4), the happening of septic shock (OR 16.5; 95 % CI 6.1–44.9) and
age > 40 years (OR 6.47; 95 % CI 1.7–23.8).
Conclusions: Melioidosis should be recognized as an opportunistic nonfatal infection for healthy person. Prompt early
diagnosis and appropriate antibiotics administration and critical care help in improved management and minimizing risks
for death.
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Background
Melioidosis occurs predominantly in Southeast Asia, north-
ern Australia, the Indian subcontinent and China. Cases
were first described in Burma 1912, Malaysia and Singapore
1913, Vietnam 1925 and Indonesia 1929. However, al-
though Thailand and Australia have the highest endemicity
of melioidosis, it was not documented in both countries
before 1949 [1].
Melioidosis has emerged over the past 20 years as an im-
portant cause of morbidity, mortality, and fatal community-
acquired bacteremic pneumonia. The clinical spectrum of
melioidosis is broad; therefore, several clinical classifications
were proposed [2]. Burkholderia pseudomallei strains differ
in their ability to cause disease and the outcome depends
on the immune status and response of the infected host.
The incubation period is approximately 21 days which
starts from the event of infection and extends until the on-
set of symptoms appearance. Nevertheless, the period has
not been accurately estimated [3, 4].
Many of the cases of melioidosis occur in individuals
with pre-existing illnesses; up to 80 % of melioidosis
patients have one or more risk factor, whereas risk factors
are less common in children [4]. The majority of recog-
nised underlying risk factors in melioidosis patients are
type II diabetes mellitus, chronic renal failure, and im-
munosuppressive treatments, in particular steroids [5].
The highly variable presentations of melioidosis make the
clinical diagnosis impossible without the aid of confirma-
tory laboratory testing. Melioidosis should be suspected in
cases of febrile illnesses presenting with respiratory failure,
multiple subcutaneous lesions, or radiological pattern
similar to that of tuberculosis, especially in diabetic pa-
tients, or those who resided or travelled to endemic areas
[3]. As many saprophytes, B. pseudomallei is intrinsically
resistant to many antibiotics including aminoglycosides
and earlier generation cephalosporins [4].
In Malaysia, Deris et al. [6] had retrospectively studied
bacteremic melioidosis in a tertiary hospital in Kelantan
state from 2001 till 2005 and brought data on human
risk factors and clinical manifestations. The present
study was performed in the same hospital and updated
the current status of melioidosis clinical epidemiology in
that state by expanding the survey from 2001 to 2015
that covered all types of melioidosis.
Methods
Data collection & study population
The study was performed in Hospital Universiti Sains
Malaysia by reviewing the clinical history of melioidosis
patients over 15 years. This is an 800-bedded tertiary
teaching hospital that is located in Kelantan, a northeast-
ern state of Malaysia. Patients’ records were reviewed
and analyzed for demographic data, clinical characteris-
tics, management, complications and clinical outcome
using a standardized checklist. The community popula-
tion location for every patient was obtained from the ad-
dress (the city and the state) at which the patient
resided. Patient’s gender and mean age were reported
and the age group was determined as (Infant ≤ 2 years);
(>2 child ≤ 13 years); (>13 young adult ≤ 18 years); (>18
mature adult ≤ 39 years); (>39 middle-aged adult ≤
59 years); and (old adult > 59 years) [7]. In addition, pa-
tients were clustered into two groups: less than 40 years
and more than 40 years for association studies. The age
grouping was done based on previous studies which
noted that usually an individual started to acquire risk
factors for melioidosis (particularly diabetes mellitus
type 2) after the age of 40 [8, 9]. The race of patients
was reported as Malay, Chinese, Indian or others.
Environmental risks
As a part of environmental factors, the month of admission
was recorded and assigned into two seasons: dry season
(from the beginning of March until the end of October)
and rainy season (from the beginning of November until
the end of February). The exposure to environmental ele-
ments was also recorded during patients’ activity prior to
admission, including farming, military work or recent travel
to jungle or swimming in natural ponds and any other
work.
Clinical definitions
Clinical data were obtained from clinician notes as well as
from laboratory records. All cases were previously con-
firmed by culture of B. pseudomallei from infected tissue,
abscess aspirate, sputum, skin swab, blood, various kinds of
body fluids or positive radiology in case of disseminated
melioidosis with positive blood cultures. Melioidosis cases
were specifically categorized into several grouping systems:
acute versus chronic; bacteremic versus non-bacteremic or
localized versus disseminated melioidosis. Bacteremic meli-
oidosis was considered when the organism was isolated
from blood culture. Recently, the infectious disease associ-
ation of Thailand (IDAT) has classified melioidosis into
four types: 1. bacteremic multifocal infection with septi-
cemia 2. bacteremic localized infection with septicemia 3.
non-bacteremic localized infection 4. and non-focal septi-
cemia [2] based on clinical scenario of the disease and type
of specimen that gave positive culture for B. pseudomallei.
In the present study, acute melioidosis was considered
when the symptoms of confirmed melioidosis presented
aggressively in the patient. If the duration of symptoms
remained and did not resolve for more than two months,
and then the infection was reported as chronic melioid-
osis. Recurrent infection was considered in case of the
reappearance of melioidosis symptoms after the first epi-
sode treatment.
Zueter et al. BMC Infectious Diseases  (2016) 16:333 Page 2 of 11
Clinical presentations included melioidosis pneumo-
nia (or any lung infection such as empyema and bron-
chitis); infections of genitourinary (mainly prostate,
urinary tract infection and kidneys); skin infection (cel-
lulitis and intradermal abscess) and soft tissue infection
(mainly tendons, ligaments, fascia, fibrous tissue and
intramuscular deep seated abscesses), bone infection
(includes osteomyelitis and septic arthritis), brain infec-
tion (cerebral abscesses, meningitis and encephalop-
athy), liver (abscesses and enlarged liver) and spleen
(abscesses and enlarged spleen). Focal melioidosis was
defined as clinical presentation of organ malfunction
that was confirmed by laboratory tests and radiological
investigation such as computed tomography (CT) scan.
If the infection spread to other organs, thus it’s known
as disseminated (or multi-focal) melioidosis. Estimated
primary and secondary organ of involvement were de-
termined according to the clinical event and progress
of the disease. However, melioidosis with no evidence
of organ involvement (non-focal) was reported as case
of bacteremia with negative signs of organ burden.
Culture-negative septic arthritis was reported as case of
bacteremic melioidosis with clinical signs and symp-
toms of active arthritis presented with joint swelling,
tenderness and inability to move. The anatomical loca-
tion for all infections of skin, muscle, bone and joint
were determined and marked. Melioidosis cellulitis of
the foot was confirmed by swab and blood culture and
was discriminated from diabetic foot cellulitis that was
characterized by mixed poly-microbial infection.
Abscess, sepsis, severe sepsis and septic shock were
also investigated as infection parameters. Sepsis was
considered in case with temperature > 38 °C, pulse
rate > 90 beats per minute, respiratory rate > 20 breaths
per minute, pCO2 < 32 mm Hg, increased white blood
cell count (>11 X 103 cell/μl) and low blood pressure.
Septic shock was reported in patients with sepsis and
persistent unresponsive hypotension. Severe sepsis was
identified as the presence of sepsis with markers of
sepsis-related organ dysfunction.
A given case was considered as fatal melioidosis only
when the death was reported as death due to melioid-
osis. In this case, death occurred within 72 h of blood
culture positive for B. pseudomallei or clinical sepsis that
did not improve after last positive blood culture. The ef-
fective fatal event of melioidosis was characterized as
septic shock, severe sepsis, respiratory distress syn-
drome, cardiogenic shock or multi-organ failure.
Human risk factors were investigated individually for
every patient including diabetes mellitus, chronic disease
of the lungs or kidneys, immune suppression, that was
either resulted from primary immune deficiency syn-
drome, viral infection or immune suppressants. Diabetes
mellitus was considered according on clinician notes on
patient’s history, serum glucose and glycosylated haemo-
globin (HbA1C) results.
For statistical association study to examine the predic-
tion for melioidosis outcomes, human risk factors were
further grouped into a single statistical variable as the
patient had any one of the mentioned biological risk
factors.
Suspected co-morbid illnesses were reported and were
associated with mortality outcome of melioidosis: they
included co-infections with other pathogens like Gram
negative bacteria, leptospirosis, hepatitis and human im-
munodeficiency virus, heart diseases, malignancies,
haematological disorders and immune disturbances. Ad-
equate treatment was reported when proper antibiotics
were administered in accordance to the standard
guideline.
Statistical analysis
Statistical analysis was performed to investigate for
frequencies among demographic data, clinical presen-
tations and mortality. The descriptive analysis was
presented as mean and standard deviations (SD) for
normally distributed numerical variables. For categor-
ical variables; all data were presented as frequency (n)
and percentage (%).
For association statistical analysis, single and mul-
tiple logistic regression estimations were used between
the dependent (outcomes of melioidosis) and inde-
pendent (risk factors and co-morbids) variables. More-
over, simple logistic regression was used to identify
the potentially risk independent variables associated
with disseminated bacteremic melioidosis; melioidosis
pneumonia and fatal melioidosis. Univariable analyses
have examined: age ≥ 40 years old; age groups
(pediatric, children, young adult, mature adult,
middle-aged adult and old adult); diabetes mellitus;
chronic kidney disease; immune suppression; cancers,
general human risk; season on admission and expos-
ure to environmental elements. Certain clinical ill-
nesses were also included in some associations such as
bacteremia, abscesses, acute infection, infections of
the lungs, soft tissues, liver, spleen, osteoarticular tis-
sue and brain. Co-morbid factors included microbial
co-infections and chronic heart disease. Only inde-
pendent variables with p value of less than 0.25 were
selected and were further examined by multiple logis-
tic regression. Results of regression were interpreted
and presented as crude odds ratio, adjusted odds ratio,
95 % CI, and p value. Finally, conclusions were drawn
based on the statistical results. For data entry and ana-
lysis, the Statistical Package for Social Sciences (SPSS,
IBM, and Chicago, USA version 22.0) and STATA ver-
sion 8.0 were used.
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Results
Demography
The mean age of melioidosis patients was 45 (±19) years,
ranging from 6 days to 83 years, with the majority of
them were between 40 and 59 years of age. Forty two
(26.6 %) patients were females and 116 (73.4 %) were
males. Almost all subjects were Malay. Majority of pa-
tients 118 (74.7 %) came from the state of Kelantan,
mainly from Kota Bharu, Bachok, and Pasir Mas; the
rest were from Terengganu 37 (23.4 %), Kedah 2 (1.3 %)
and one patient from Perak (0.6 %). The patients were
exposed to various occupations that determined their
contact with environmental elements. Although less
than half of the patients were admitted during the rainy
season throughout the study period, the highest individ-
ual frequency of monthly admissions was observed
during November, December, January and February
compared to admissions during other month over the
year.
Clinical data
Fever, infections of the respiratory system and soft tis-
sues were commonly reported as the primary cause for
emergency and hospital admissions. Bacteremic melioid-
osis was seen in 121 (76.6 %) patients, whereas focal
melioidosis and disseminated infection were seen in 124
(78.5 %) and 45 (28.5 %) cases, respectively. Localized
melioidosis predominated in both groups of melioidosis,
bacteremic and non-bacteremic, while only five cases of
disseminated melioidosis were non-bacteremic and re-
stricted on skin and soft tissue infection. The vast major-
ity of melioidosis cases (n = 150, 94.9 %) were considered
acute infections, most of them (n = 116, 77.3 %) were
with bacteremia. Similarly, out of eight cases of chronic
melioidosis, the organism was isolated from the blood of
five patients. All types of melioidosis were seen in all age
groups, with gradual increased frequency with increased
age and peaked at middle-aged group before declining at
older age.
Among overall clinical presentations (initial and second-
ary), the lungs were the most frequently infected organs
(n = 65, 41.1 %), followed by skin and soft tissues (n = 44,
27.8 %), bone and joints (n = 20, 12.7 %), liver (n = 19,
12.0 %), spleen (n = 15, 9.5 %) and brain (n = 9, 5.7 %).
Genitourinary involvement was the least seen among the
organs (n = 5, 3.2 %). Other unusual sites of infections
were reported including parotid gland and lacrimal sacs
(n = 4, 2.5 %). For all organs, the frequency of involvement
became increased with the age; it means, no specific organ
involvement was restricted to infancy, childhood and ado-
lescent age groups.
Skin cellulitis, intradermal abscesses and intramuscular
deep seated abscesses were reported in various anatomic
locations (Table 1). In addition, tibial osteomyelitis was
seen in two cases and septic arthritis of different joints
was reported in 24 cases that were diagnosed either clin-
ically or by culture (Table 2).
Sepsis, severe sepsis and septic shock were reported in
109 (69 %), 26 (16.5 %) and 54 (34.2 %) cases respect-
ively. In addition to the expected primary organ involve-
ment, subsequent clinically-evident secondary organ
involvements were reported and examples are shown in
Table 3.
Predisposing risk factors were reported in most of pa-
tients (n = 133, 84.2 %). Diabetes mellitus was the major
predisposing factor in all but not children and young
adults’ patients. Diabetes mellitus was present in 118
(74.7 %) patients. Other risk factors were immune dis-
turbances (n = 15, 9.5 %), cancer (n = 7(4.4 %) and
chronic kidney disease (n = 18, 11.4 %).
Diagnosis and treatment
All cases were confirmed by cultivation of the organism
from various clinical specimens. Only eight cases of septic
arthritis were diagnosed clinically, serologically and by iso-
lation of the organism from blood but not the synovial
fluid. On admission, serology (IgM-indirect fluorescent
assay and/or IgM/IgG-enzyme linked immunosorbent assay
ELISA) was done for 50 patients and was positive for all,
whereas the total white blood cell count ranged from 1.0 X




























aA single patient may had several abscesses and/or cellulitis
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103 cell/μl to 39.90 X 103 cell/μl with the mean (± SD) of
13.85 X 103 cells/μl (±6.67 X 103 cells/μl)
Patients received empirical antimicrobial treatment
prior to the availability of culture results, which was
given based on the severity of the infection and sus-
pected source of sepsis. In cases of high-grade fever,
the empirical treatment comprised imipenem, ceftazi-
dime, meropenem or piperacillin-tazobactam, while in
less severe cases, in particular with suspected skin ab-
scess origin, cloxacillin, cefotaxime, cefuroxime, metro-
nidazole, azithromycin, fluconazole or ceftriaxone were
administered. Standard melioidosis treatment was initi-
ated upon culture and identification of B. pseudomallei
results which were routinely available after 2 to 5 days.
Intravenous ceftazidime 50 mg/kg (up to 2 g every 8 h)
was given for infection with mild symptoms with no
complications. In cases of severe acute infections and
suspected dissemination, intravenous meropenem
25 mg/kg (up to 1 g every 8 h) or intravenous imipe-
nem 20 mg/kg every 8 h were given. The duration of
the first-line therapy was 10–14 days, which was ex-
tended to more than 4 weeks in cases of more severe
disease. For eradication phase of treatment, oral tri-
methoprim/sulfamethoxazole (160 mg/800 mg 2 tablets
every 12 h for 12–20 weeks) or amoxicillin/clavulanate
(500 mg/125 mg; three tablets every 8 h for 12–20
weeks) were administered.
Disease outcomes and co-morbidity
Death due to melioidosis was reported in 52 (32.9 %) of
patients and recurrent infection occurred in four (2.6 %)
patients. Twelve cases of fatal melioidosis cases seen in
this study were directly attributed to the absence of
prompt acute-phase treatment. Delayed admission, in-
complete treatment course and missed and delayed diag-
nosis were frequently reported among patients with
recurrent melioidosis. All patients with recurrent meli-
oidosis succumbed to death in the last infection episode.
Fifty one (32.3 %) patients suffered from other illnesses
including co-infections (n = 17, 10.8 %), chronic heart dis-
eases (n = 4, 2.5 %), immune disturbances (n = 15, 9.5 %),
cancer (n = 7, 4.4 %) and chronic kidney disease (n = 18,
11.4 %). Among fatal cases, the disease ended with severe
respiratory disease (n = 17), septic shock (n = 16), severe
sepsis (n = 9), cardiogenic shock (n = 6), multi-organ fail-
ure (n = 3) and severe meningitis (n = 1).
Association of risk factors with melioidosis
On simple logistic regression, neither human nor environ-
mental risk factors were individually associated with dis-
seminated septicemic melioidosis. However, when all
human risks factors were grouped into a single independent
variable, p value turned into statistically significant and the
corresponding crude odd ratio and confidence interval be-
came significant as well. On the contrary, the same analysis
showed statistical and clinical significant associations of
several individual clinical illnesses with disease dissemin-
ation. Multiple logistic regression analysis supported by
model-fitness tests has defined the most probable risk fac-
tors that predicted the disease dissemination throughout
body organs and tissues. Melioidosis patients had 4.36
times the odd to develop dissemination of the infection
away from the site of origin (95 % CI 1.75, 10.84, p = 0.002)
when adjusted for predisposing human risk factor. In



















aA single patient may had several joints involvement
Table 3 Secondary clinical foci for major primary diagnostic groups
Primary diagnosis Total
number
Number with secondary foci (% of
total)
Most common secondary focia
Pneumonia 59 30(50.8 %) 8 skin and soft tissues, 8 liver, 5 spleen, 5 brain and 4
osteoarticular
Skin & soft tissue
infection
34 19(55.8 %) 5 lungs, 8 skin and soft tissue, 1 liver, 1 spleen and 4
osteoarticular
Liver infection 7 4(57.1 %) 3 spleen and 1 osteoarticular
Spleen infection 2 1(50.0 %) 1 liver
Osteoarticular infection 18 12(66.6 %) 2 lungs, 1 skin and soft tissue, 3 liver and 6 osteoarticular
Brain infection 2 1(50.0 %) 1 liver
Prostate infection 3 2(66.6 %) 1 skin and soft tissue and 1 liver
aMore than single secondary focus found in some cases
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addition, melioidosis patients had 13.83 times the odd to
develop dissemination (95 % CI 2.26, 84.51, p = 0.004) when
adjusted for bacteremia. However, other clinical conditions
had increased the odd times for dissemination including
lung melioidosis, skin and soft tissue melioidosis, osteoarti-
cular infections and melioidotic abscesses (Table 4). In
addition, patients with age ≥ 40 years had estimated risk for
developing melioidosis pneumonia and fatal outcomes,
whereas treatment has improved the mortality prediction
of melioidosis (95 % CI 6.94, 12.63, p = 0.001) when ad-
justed for treatment (Tables 5 and 6).
Discussion
We explored the clinical characteristics of melioidosis in
the Northeastern part of Malaysia and have updated the lit-
erature databases with latest statistics related to the disease.
In this study, melioidosis was frequently reported among
middle-aged patients, as reported in other surveys [8–10]
that linked the reason with the acquiring of risk illnesses
with aging. For example, type two diabetes mellitus is the
prominent risk factor for melioidosis and is usually newly
diagnosed in mature adults, which in turn will increase the
risk of the infection. On the contrary, children, adolescent
and young adult age groups have minor infections probably
due to relative lack of predisposition. However, a few epi-
demiological surveys and case reports of melioidosis in
these age groups have been published in Malaysia and else-
where [11–19].
In this study, males were more risky for acquiring the
infection than females; probably because of the differ-
ences in exposure to bacterial reservoir such as soil dur-
ing rice farming and inhalation of contaminated dust.
The male-to-female ratio for melioidosis was higher in
all studies performed in Malaysia, Australia, and
Singapore [8, 9, 20, 21]. The vast majority of patients
were Malay, since the patients came primarily from dif-
ferent locations in Kelantan state, as well as from Kuala
Besut, Terengganu. Both states are predominated by
Malay race population. Same findings were reported by
Hassan et al. [9] who analysed data of 129 Malay pa-
tients in Kedah, a state that resembles Kelantan in ethnic
demography.
Farming, military works and other occupational activ-
ities were reported. Although limited data were col-
lected about the patients’ occupation due to missing of
records, environmental exposure was expected since
the majority of patients were originated from rural and
agricultural regions in Kelantan. In Kedah state, farm-
ing, fishing and forestry were common occupations for
admitted patients [9]. In Thailand 81 % of melioidosis
cases were diagnosed in rural rice farmers and their
children [22], whereas in Singapore, melioidosis has oc-
curred in construction workers, gardeners and military
personnel [20]. Similarly, 75 % of melioidosis cases in
Northern Australia were associated with recreational
activities resulting in exposure to environmental B.
Table 4 Factors associated with septicemic melioidosis with
























































- aSimple logistic regression, bMultiple logistic regression
Table 5 Factors associated with melioidosis pneumonia among











Less than 40 years 1.00















- aSimple logistic regression, bMultiple logistic regression
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pseudomallei, whereas 18 % of the cases had clear oc-
cupational exposure [8].
Months from November till February represent the rainy
season in the eastern coast of Peninsular Malaysia in which
extreme weather changes happen including flooding. This
may facilitate dynamic distribution of B. pseudomallei in
the environment and thus increasing bacterial infective load
in surface water and soil. Moreover, epidemiologic data
suggested that massive volumes of rainfall result in raising
the water level on land, which leads to the accumulation of
B. pseudomallei on surface soil and becomes a reservoir for
inhalation of aerosolized bacteria for human and animal. In
addition, bacterial cells might be carried far away from their
reservoirs to contaminate water sources and farms [23–25].
Recently, an outbreak of melioidosis was documented
during the flood that hit Malaysia in December 2014 in
which 20 cases were confirmed in the affected places. An-
other post-flood melioidosis report by Pahang state health
officials documented 21 melioidosis cases detected during
the first 2 months of 2015, in comparison to 16 cases
throughout 2014 (http://www.worldwideoutbreak.com). In
Kedah, melioidosis cases and deaths were highest in the
wettest months in Kedah state [9]. In general, the correl-
ation between melioidosis and rainfall is much stronger in
northeast Thailand and northern Australia that experience,
like Kelantan state, an intensely wet and windy season, and
a dry season with very little rain [23, 26].
However, these findings disagreed with those obtained
from Kuala Lumpur state and Singapore reports that
suggested no association between rainfall intensity and
melioidosis; but instead, it was attributed to decreased
environmental and agricultural areas. In addition, the
rainfall is relatively even along the year with no distinct
wet or dry seasons [25, 27]. In contrast, a recent report
from Singapore reviewed 550 melioidosis cases along a
10-year period in a highly urbanized city had found an
association of rainfall and humidity levels with disease
incidence. It was suggested that water, rather than soil,
might be the central vehicle for transmission and acqui-
sition of this disease, in particular, most patients in this
study did not report occupational or recreational expos-
ure to soil [28]. The assumption from that study might
be supported by a recent Thai matched case–control
study and other studies from Australia which suggested
that acquisition of B. pseudomallei after ingestion of un-
chlorinated domestic water supplies might be more
common than previously thought [29–31].
In this study, melioidosis pneumonia and soft tissue
infections were repeatedly seen. In general, fever and re-
spiratory symptoms are well characterized manifestations
that require urgent admissions. In addition, abscess-
induced swelling with tenderness was the most common
primary presentation of soft tissue melioidosis that might
be accompanied with fever in case of dissemination [8].
However, the infection acquisition route may determine
the primary manifestations of disease. Inhalation of
aerosolized dust and percutaneous bacterial inoculation
are the most common infection route that resulted in
higher frequencies of pneumonia and skin and soft tissue
abscesses and cellulitis, respectively [2].
Acute bacteremic melioidosis with organ involvement
was seen in most of patients. Majority of melioidosis
surveys focused on bacteremic melioidosis due to its
higher frequency [6, 8]. Although dissemination occurs
after hematogenous spread of bacteria from one organ
to another, five cases of disseminated soft tissue melioid-
osis were reported in this study without isolation of bac-
teria from blood samples probably because of the close
distances between the infected foci.
Melioidosis was seen in all age group, particularly at the
middle age. However, McLeod et al. [15] reported in-
creased frequency of non-bacteremic localized melioidosis
Table 6 Factors associated with death due to melioidosis among 158 patients from multiple logistic regression analysis
Variable Crude OR (95 % CI)a Adjusted OR (95 % CI)b Wald Statistics (df) p value
Age
Less than 40 years 1.00
Equal to or more than 40 years 2.48 (1.09, 5.64) 6.47 (1.79, 23.38) 8.11 (1) 0.004
Septic shock
Not presented 1.00
Presented 14.00 (6.22, 31.50) 16.55 (6.10, 44.90) 30.34 (1) 0.001
Co-morbidity
Not presented 1.00
Presented 2.25 (1.11, 4.55) 3.06 (1.12, 8.41) 4.72 (1) 0.030
Anti-melioidosis therapy
Not Given 1.00
Given 35.03 (4.40, 27.66) 16 (6.94, 12.63) 11.64 (1) 0.001
aSimple logistic regression, bMultiple logistic regression
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in age group less than 16 years and attributed that differ-
ence to lack of risk factors in this age group that induce
bacteremia and dissemination.
On the other hand, septic arthritis, intra-organ ab-
scesses of brain, spleen, liver, prostate and bone tissue
were more attributed with secondary hematogenic
spread of bacteria from the original infected foci. How-
ever, some cases of septic arthritis were secondary to ad-
jacent intradermal abscesses [32]. Septic arthritis and
osteomyelitis due to B. pseudomallei are rare but still
considered well-recognized presentations of melioidosis
[33]. In the present study, only 20 cases of osteoarticular
involvement were reported over 15 years review, which
concurs with other previous surveys [6, 8]. The reason
behind the low-rate involvement of osteoarticular tissue
in melioidosis might be attributed to the low blood sup-
ply to these locations comparing to other organs and, in
parallel, the fact that the majority of melioidosis cases
are bacteremic and affect mostly organs rich with blood
supply such as liver, spleen, lungs and brain [34, 35]. In
another study performed in tropical Australia, the per-
centages of primary and secondary melioidotic septic
arthritis among 536 confirmed cases were 2.4 % and
2.6 %, respectively [36].
Cellulitis and abscesses were reported in various ana-
tomic locations without predominance in one location
over another and were either singly or secondary to each
other or to different primary infected foci. This pattern
of infection distribution reflected the unspecific behavior
of the bacteria during its pathogenesis toward certain
anatomic location. Same infection pattern was observed
for septic arthritis but with predominance of infection of
the knee. In a study done by Pui and Tan [37] the knee
was the most common infected location followed by
ankle, foot, shoulder and hip; results agree with our find-
ings and other reports [32, 36].
In contrast to adult melioidosis, it was reported that
non-bacteremic melioidosis associated with skin and soft
tissue was more frequent in patients less than 16 years
old rather than bacteremic pneumonic melioidosis [15].
In this study, melioidosis among this age group did not
show disease manifestations that differ from those in
adults, which might be due to low number of reviewed
patients under this age category to enable adequate
discrimination.
Unlike reports from northern Australia [38] and
Thailand [22], genitourinary and parotid melioidosis
were the least seen among the infected organs in this
study. It was postulated that there are regional difference
in melioidosis presentation that was either due to host,
bacterial, or environmental factors [39]. However, in
spite of intensive previous works to discover the fact be-
hind regional difference in melioidosis clinical presenta-
tions, conclusions have been difficult to make from
relatively small sample sizes and then reasons for this
difference remain unclear [40, 41]. Most of the less com-
mon presentations of melioidosis seen in this study have
also been described in other reports including parotid
gland [42] and lacrimal sac [43].
Dissemination of the infection to other organs might
lead to microbial colonization inside deep seated abscess
that interfere with normal organs functions [44]. In the
present study, approximately 60 % of primary lung, soft
tissue and osteoarticular melioidosis cases exhibited dis-
semination to secondary organs. In general, whatever
the primary clinical presentation of melioidosis was, sec-
ondary focal dissemination is common, presumably from
bacteremic spread, which was reported in 76.6 % in our
patients. Secondary pneumonia, soft tissue and septic
arthritis were also common [8]. Musculoskeletal meli-
oidosis is rare but not uncommon; septic arthritis and
osteomyelitis are usually secondary infections commonly
occur following bacterial dissemination from infection
elsewhere in the body. To a lesser extent, septic arthritis
or osteomyelitis can be the primary manifestation of
melioidosis. The commonest musculoskeletal melioid-
osis presentations are soft tissue involvement, followed
by osteomyelitis, septic arthritis and, less common, spine
infection [36].
Melioidosis occurs commonly in individuals with pre-
existing illnesses; up to 80 % of melioidosis patients have
one or more risk factors, whereas risk factors are less
common in children [11, 15]. In our study, predisposing
risk factors were reported in most of patients. Type two
diabetes mellitus was the major predisposing factor in all
but not children and young adults’ with nearly all had
chronic uncontrolled type 2 diabetes. In Malaysia, the
rate of diabetes mellitus in patients with bacteremic
melioidosis was 56 % [9]. Another reported risk factor
was immune disturbance due to cancer or autoimmunity
medications, primary immune deficiency condition or
chronic kidney disease. However, 25 (15.8 %) of patients
did not have any reported predisposing factor. In
Australia, both hazardous alcoholism and type 2 diabetes
mellitus were equally reported as frank risk factors for
melioidosis in 39 % of patients and showed similar mor-
tality rates in Australia [8], whereas only type 2 diabetes
mellitus was the predominant predisposing factor in
Malaysia [6, 9, 45].
In this study, mortality rate was 32.9 %. The mortality
rate of acute melioidosis was stated as 19-40 % in en-
demic countries including Singapore, Northern
Australia, northern Thailand and Malaysia [9, 20, 30].
Untreated bacteremic melioidosis increases the mortal-
ity rates upon hospital admission [46]. In the present
study, the absence of prompt acute-phase treatment
was common cause of death in some cases, which
might be related to delayed admissions of severe cases
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that lead to fatal outcomes despite the administration
of standard empirical treatment. In addition, some
cases with fever and skin abscess were treated empiric-
ally for suspected Gram positive or fungal sepsis. This
study reported 13 patients who received only empirical
treatment that might have failed to save their lives.
Deris et al. [6] and other literatures have recommended
urgent laboratory diagnosis and increased level of meli-
oidosis suspicion to improve the management and re-
duce mortality.
In the present study, recurrent infections were attributed
to delayed admission, incomplete treatment course and
missed or delayed diagnosis. In Thailand, the overall recur-
rent infections were up to 30 % per year of survivors who
had severe melioidosis [47]. While in Malaysia, the rate of
recurrence was approximately 13 % over a period of 5 years
[3]. Early hospital admission, prompt diagnosis and treat-
ment and completion of medication course will reduce re-
current infections [4]. Four patients had several recurrent
infections episodes and all succumbed to the infections. For
some patients, disease pattern and bacterial genotype were
not similar during the different episodes of the infections
which suggest diversity of bacterial genotypes in a given
geographical area. It was reported that recurrent infection
occurs in 6–13 % of melioidosis cases due to relapse of the
infection by the same bacterial strain rather than reinfec-
tion with a new bacterial strain, especially when occurring
within a year of primary infection [48]. In a study, 140 pa-
tients with recurrent melioidosis showed similar patterns of
disease occurred during different disease episodes, regard-
less of whether this was caused by relapse or re-infection
[49]. Chronic co-morbid illnesses are common in melioid-
osis patients and worsen the clinical presentation of the dis-
ease and might be influenced with mortality [2].
The present study has defined the probable risk factors
associated with disseminated and lung melioidosis and
fatal outcomes. Among the considered risk factors, dia-
betes mellitus is responsible for abnormal increased
blood sugar, whereas chronic immune syndromes com-
promise the circulating immunity; together, both condi-
tions facilitate bacteremia, which induce haematogenous
spread of bacteria away from the origin of the infection
[50]. The association of diabetes with bacteremic meli-
oidosis has been noted in Thailand [24]. Lungs and soft
tissues are common sites of infection and are well con-
nected with capillary networks for blood supply due to
their vital functional role for the body; this physiological
role may expose these organs for the infection via circu-
lating bacteria. In addition, B. pseudomallei experience
chronic persistence inside osteoarticular tissues upon
colonizing various organs and tissues and stay inside
cysts and abscesses that represent bacterial source and
reservoir from which the bacteria may spread and get
access to other organs [4]. In Australia, age, diabetes,
alcoholism and chronic illness were associated with
bacteremic melioidosis [8], whereas diabetes mellitus
was the predominant associated risk factor with
bacteremic melioidosis in the same study area [6].
In this study, melioidotic bacteremia and age ≥ 40 years
were each associated with a propensity for presentation
with pneumonia in comparison to other presentations.
Currie et al. [8] had stated risk factors associated with
melioidosis pneumonia; on simple logistic regression
age ≥ 50 years and diabetes mellitus showed significant
increase in the odd for developing pneumonia. However,
multiple logistic analyses reported the association of
chronic illnesses, alcohol and Kava consumption with
melioidosis pneumonia.
In this study, age ≥ 40 years, septic shock and co-
morbid illnesses were independent predictors for mortal-
ity. In addition, anti-melioidosis treatment had improved
protection against fatal disease outcomes. In Australia,
only age ≥ 50 years and pre-disposing risk were associ-
ated with mortality [8], whereas in Malaysia, patients
with diabetes suffered significantly more mortality from
melioidosis, this relationship was more influenced by age
[9]. Another report from Kuala Lumpur, Malaysia had
studied the predictors of severe disease or death for 85
melioidosis patients and stated that male patients with
age more than 40 years old and diabetes mellitus were
the most significantly associated with bad prognosis and
death; severe disease or death occurred in 28 (32.9 %) of
cases [51]. Septic shock is the normal pathological con-
sequence following bacterial colonization in blood ves-
sels; in this study, sepsis was reported in 69 % of
bacteremic melioidosis cases that in turn increase the
chance for fatal septic shock. Again, the increase in the
age has led to worsen disease events, prognosis and out-
comes due to presence of predisposing factors that may
become life-threatening co-morbid illnesses. Treatment
outcomes are somewhat satisfactory which were attrib-
uted to prompt administration of the proper antibiotic
in majority of cases as well as the absence of
carbapenem-resistant strains of B. pseudomallei in the
area of the study [45, 52–54].
Conclusion
This study has provided a major review for melioid-
osis among selected population clusters residing the
Northeastern part of Peninsular Malaysia. Diabetes
mellitus is the major risk factor for bacteremic meli-
oidosis, which is the most common type of the infec-
tion. Thus efforts toward disease prevention may
include evading conditions that predispose melioidosis
by controlling, for example, food habits and life style
associated with diabetes and provide complete man-
agement for diabetic patients to reduce its incidences.
These precautions must target age group more than
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40 years old due to increased disease risk in this age
stage. In addition, advices must be provided to people
in both rural and urban areas regarding water hygiene
and precautions must be made during rainy seasons
by increasing the level of suspicion of melioidosis in
the medical wards and to minimize personal contact
with environmental elements to reduce their exposure
to contaminated particles.
Disease management in this study has successfully
reduced the incidence of undiagnosed fatal melioidosis
to minimum, however, still the ambition for further re-
ducing the incidence by the addition of rapid point-of-
care testing for melioidosis to provide prompt diagnosis
and selective treatment. For clinical epidemiology
study, more cases could be further reviewed from other
hospitals and medical institutes throughout Malaysia to
provide complete picture for melioidosis status that
may uncover new correlations and insights for further
understanding of the disease and improve management.
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